Table 1.

Characteristics and laboratory findings in all groups

	Group 1 (n=18)	Group 2 (n=44)	Group 3 (n=16)	p
Age (years)	57.5±7.0	59.7±8.7	59.9±11.6	NS
Gender (male/female)	11/7	18/26	10/6	NS
Glucose (mg/dL)	335.4±166.1	356.6±156.5	285.4±140.0	NS
Creatinine (mg/dL)	0.9±0.3	1.0±0.3	0.9±0.3	NS
ALT (U/L)	17.7±16.3	19.1±16.7	17.1±6.9	NS
A1c (%)	11.2±3.3	11.4±2.3	10.1±2.4	NS
WBC (109/L)	9.9±3.9a, b	15.1±7.1	15.7±7.8	0.016
Hgb (g/dL)	12.5±1.7c	11.6±1.8	10.9±1.5	0.029
PLT (109/L)	303.6±95.8	379.37±150.1	410.6±127.1	NS
CRP (mg/dL)	4.1±4.5c, d	15.8±10.8	12.6±8.8	<0.001
ESR (mm/h)	56.4±17.7d, e	83.8±28.7	95.1±26.1	<0.001
PLR	140.8±42.6f	185.7±90.2	222.1±95.5	0.02
NLR	2.8±0.9g, h	6.0±5.2	6.9±5.3	0.022
Length of stay (days)	7.9±2.7i	15.0±8.9	12.5±8.9	0.009
Cost of stay (TL)	1,310.8±500.0f	2,966.9±2,105.0	3,488.1±3,603.1	0.02

A1c: glycosylated hemoglobin; ALT: alanine aminotransferase; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; Hgb: hemoglobin; NLR: neutrophil-to-lymphocyte ratio; PLO: platelet-to-lymphocyte ratio; PLT: platelet; WBC: white blood cell

^ap=0.008 between group 1 and group 2;

^bp=0.015 between group 1 and group 3;

^cp=0.009 between group 1 and group 3;

^dp<0.001 between group 1 and group 2;

^ep<0.001 between group 1 and group 3;

^fp=0.006 between group 1 and group 3;

^gp=0.017 between group 1 and group 2;

^hp=0.011 between group 1 and group 3;

ⁱp=0.002 between group 1 and group 3